The trademark ImmunoBiome was filed by IMMUNOBIOME Inc., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on March 24, 2020, and received one opposition filed on June 23, 2020 by Optibiotix Limited on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by APPLEYARD LEES IP LLP and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 23, 2020
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Immunostimulants, immunomodulators, diagnostic reagents for immunization disease, pharmaceutical preparations for the prevention of disorders of the immune system, pharmaceutical preparations for the prevention of diseases of the immune system, pharmaceutical preparations for regulating the immune system and all the abovementioned goods only for oral and subcutaneous application, intravenous and intra-muscular injections, nasal inhalation, and mucosal absorption, and for treatment of inflammations, of cancer, of autoimmune diseases, of trans-plant rejection and of neurological diseases, and not related to the treatment of the respiratory tract..
The mark was filed in class 44 with Advice relating to immunology, therapy services.